Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Shorter antibiotic course for diabetic foot infection tested – but trial never started

NCT ID NCT05074147

Disease control Sponsor: Tourcoing Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled This study
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study aimed to see if a 3-week course of antibiotics works as well as a 6-week course for treating bone infections in the feet of people with diabetes. The trial planned to include adults with diabetes and a forefoot bone infection treated without surgery. However, the study was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
antibiotics (rifampin, ofloxacin, levofloxacin, ciprofloxacin, clindamycin, fusidic acid, teicoplanin, ceftazidime, trimethoprim)
What this could lead to
If successful, this could show that a shorter 3-week antibiotic course works as well as 6 weeks for diabetic foot bone infections, reducing side effects and treatment burden.
What could go wrong
The trial was withdrawn before any patients enrolled, so no results are available. It is unclear if shorter treatment is truly effective or safe.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Started

May 2022

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient aged ≥ 18 years * Informed, written consent obtained from patient * Patient having the rights to Frenc social insurrance * For women of childbearing potential : any effective contraceptive is required * Type 1 or 2 diabetic patients * Diabetic patients treated non-surgically for an osteomyelitis of the forefoot affecting only one osteoarticular part/radial supported by adequate diagnostic imaging and bone biopsy performed through uninfected tissue. * Two peripheral pulses or transcutaneous oxygen tension measurement (TcPO2 \> 30mmHg) or ankle brachial index (ABI \> 0.9) * Patient without antibiotherapy during 2 weeks before D1. * Glycated hemoglobin (HbA1C) \< 12% ( measured maximum 2 months before D1) * Use of offloading boot for diabetic foot is feasible Exclusion Criteria: * Bone fragmentation, articular destruction requiring bone resection or amputation. * Gangrene * More than one osteoarticular part/radial affected * Contraindication for the use of offloading boot * Contraindication for bone biopsy * Contraindication for the full course of antibiotics (allergy or based on RCP) * Other drug-drug interaction that contraindicated the full course of antibiotics * Charcot foot * Patient undergoing radiotherapy of chimiotherapy for malignant neoplasms * Hepatic insufficiency (ASAT and/or ALAT \> 3 times the normal level) * Any disease or behaviour making impossible to follow the protocol or difficult to interpret the results * Any disease or context making difficult to allow regular monitoring of the patient * Participation in other interventional research during the study * Curator or guardianship of patient placed under judicial protection * Pregnancy or lactating women

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Osteomyelitis - foot are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diabetes mellitus osteomyelitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Osteomyelitis - foot

Contacts and locations

Locations

  • AP-HP Ambroise Paré

    Boulogne-Billancourt, France

  • AP-HP Cochin

    Paris, France

  • AP-HP Lariboisière

    Paris, France

  • Centre Hopitalier Universitaire de Brest

    Brest, France

  • Centre Hospitalier Universitaire de Caen

    Caen, France

  • Centre Hospitalier Universitaire de Lille

    Lille, France

  • Centre Hospitalier Universitaire de Montpellier

    Montpellier, France

  • Centre Hospitalier Universitaire de Nantes

    Nantes, France

  • Centre Hospitalier Universitaire de Rouen

    Rouen, France

  • Centre Hospitalier de Boulogne-sur-Mer

    Boulogne-sur-Mer, France

  • Centre Hospitalier de Béthune-Beuvry

    Béthune, France

  • Centre Hospitalier de Compiègne-Noyon

    Compiègne, France

  • Centre Hospitalier de Dunkerque

    Dunkirk, France

  • Centre Hospitalier de Lens

    Lens, France

  • Centre Hospitalier de Roubaix

    Roubaix, 59100, France

  • Centre Hospitalier de Valenciennes

    Valenciennes, France

  • GHICL Saint-Philibert

    Lomme, France

  • GHICL Saint-Vincent de Paul

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.